You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotoxin HA22

Showing 1 - 25 of 3,069
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

Active, not recruiting
  • Hairy Cell Leukemia
  • Moxetumomab Pasudotox-tdfk
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Acute Lymphoblastic Leukemia Treated With Anti-CD22

Recruiting
  • Acute Lymphoblastic Leukemia
  • Anti-CD22 Immunotoxin
  • Meldola (FC), FC, Italy
  • +4 more
Feb 25, 2021

Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)

Approved for marketing
  • Relapsed/Refractory Hairy Cell Leukemia
  • Moxetumomab Pasudotox
  • (no location specified)
Jun 26, 2020

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
Aug 12, 2021

Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

Recruiting
  • Non-Hodgkins Lymphoma
  • Charlotte, North Carolina
  • +21 more
Jan 18, 2023

Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

Active, not recruiting
Has Results
  • Hairy Cell Leukemia
  • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022

COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222, AZD2816)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • AZD2816
  • Brasilia, Brazil
  • +34 more
Jun 27, 2022

Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Naproxen, Diclofenac)

Terminated
  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Phoenix, Arizona
  • +14 more
Aug 24, 2021

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

Completed
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 28, 2022

Postmenopausal Osteoporosis Trial in Worldwide (Romozosumab, Teriparatide)

Completed
Has Results
  • Postmenopausal Osteoporosis
  • Gainesville, Georgia
  • +49 more
Nov 4, 2022

Osteoarthritis, Knee Trial in Northwood (APS)

Completed
  • Osteoarthritis, Knee
  • APS
  • Northwood, United Kingdom
    BMI Bishops Wood Hospital
Jun 11, 2020

Mesothelioma Trial run by the NCI (LMB-100, Pembrolizumab)

Terminated
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 3, 2021

Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part

Completed
  • Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • Truro, Cornwall, United Kingdom
  • +35 more
May 18, 2022

Refractory B-Lineage Leukemia, Relapsed B-Lineage Leukemia, Refractory B-Lineage Lymphoma Trial in Minneapolis (DT2219ARL)

Completed
Has Results
  • Refractory B-Lineage Leukemia
  • +3 more
  • DT2219ARL
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 27, 2019

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Osteoarthritis Trial in United Kingdom (Total Ankle Replacement, Arthrodesis)

Active, not recruiting
  • Osteoarthritis
  • Total Ankle Replacement
  • Arthrodesis
  • Truro, Cornwall, United Kingdom
  • +16 more
Mar 12, 2021

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,

    Active, not recruiting
    Has Results
    • Neoplasms With Mesothelin Expression
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2022

    Adult B Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia Trial in Bronx, Philadelphia (drug,

    Terminated
    • Adult B Acute Lymphoblastic Leukemia
    • Recurrent Adult Acute Lymphoblastic Leukemia
    • Bronx, New York
    • +1 more
    Sep 4, 2019

    Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

    Not yet recruiting
    • Newly Diagnosed MGMT Unmethylated Glioblastoma
    • Durham, North Carolina
      Duke University Medical Center
    Feb 7, 2023

    Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,

    Completed
    • Intracranial Hemorrhages
    • +8 more
    • Edinburgh, Midlothian, United Kingdom
    • +66 more
    Mar 31, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

    Active, not recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Tagraxofusp-erzs
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 8, 2022

    Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Placebo)

    Completed
    • Osteoarthritis, Knee
    • Osteoarthritis, Hip
    • Glendale, Arizona
    • +46 more
    Dec 2, 2021

    Moderate-to-severe Atopic Dermatitis Trial in China (CBP-201, Placebo)

    Recruiting
    • Moderate-to-severe Atopic Dermatitis
    • Hefei, Anhui, China
    • +55 more
    Sep 22, 2021

    Painful Osteoarthritis of the Knee Trial in Worldwide (MEDI7352, Placebo)

    Recruiting
    • Painful Osteoarthritis of the Knee
    • MEDI7352
    • Placebo
    • Montclair, California
    • +92 more
    Aug 24, 2022